Association of changes in histological severity of non-alcoholic steatohepatitis and changes in patient-reported quality of life

Association of changes in histological severity of non-alcoholic steatohepatitis and changes in patient-reported quality of life

Nonalcoholic steatohepatitis (NASH) is a prevalent chronic disease that is associated with a spectrum of liver fibrosis and can lead to cirrhosis. Patients with NASH report lower health-related quality of life (HRQoL) than the general population. It remains uncertain how changes in histologic severi...

Szczegółowa specyfikacja

Opis bibliograficzny
Główni autorzy:	Heath, L, Aveyard, P, Tomlinson, J, Cobbold, JF, Koutoukidis, DA
Format:	Journal article
Język:	English
Wydane:	Wiley 2022

Podobne zapisy

Association of changes in histologic severity of nonalcoholic steatohepatitis and changes in patient‐reported quality of life
od: Laura Heath, i wsp.
Wydane: (2022-10-01)

Association of weight changes with changes in histological features and blood markers in non-alcoholic steatohepatitis
od: Koutoukidis, D, i wsp.
Wydane: (2021)

A low-energy total diet replacement programme demonstrates a favourable safety profile and improves liver disease severity in non-alcoholic steatohepatitis
od: Koutoukidis, D, i wsp.
Wydane: (2023)

Comparison of clinical, biochemical and histological features of alcoholic steatohepatitis and non-alcoholic steatohepatitis in Asian Indian patients
od: Singh Deepak, i wsp.
Wydane: (2010-07-01)

Clinical and histological features of non-Alcoholic steatohepatitis in Iranian patients
od: "Ebrahimi Daryani N, i wsp.
Wydane: (2003-03-01)

Clinical and histological features of non-Alcoholic steatohepatitis in Iranian patients
od: "Ebrahimi Daryani N, i wsp.
Wydane: (2003-05-01)

Changes in intestinal permeability and gut microbiota following diet-induced weight loss in patients with metabolic dysfunction-associated steatohepatitis and liver fibrosis
od: Dimitrios A. Koutoukidis, i wsp.
Wydane: (2024-12-01)

The Correlation between Serum Zinc Level and Liver Histology in Non-Alcoholic Steatohepatitis
od: Farid Kosari, i wsp.
Wydane: (2019-01-01)

The Role of Epigenetic Changes in the Progression of Alcoholic Steatohepatitis
od: Hyeong Geug Kim, i wsp.
Wydane: (2021-07-01)

Systematic review: the diagnosis and staging of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis.
od: Dowman, J, i wsp.
Wydane: (2011)

What proportion of people have a follow-up biopsy in randomized trials of treatments for non-alcoholic steatohepatitis?: A systematic review and meta-analysis
od: Koutoukidis, DA, i wsp.
Wydane: (2021)

Changes in rat liver fatty acid profile in experimental non-alcoholic steatohepatitis
od: E. B. Shustov, i wsp.
Wydane: (2021-12-01)

Non-alcoholic Steatohepatitis: An Overview
od: Allison Shifflet, i wsp.
Wydane: (2009-01-01)

Endocannabinoids and non-alcoholic steatohepatitis
od: Helmy Ahmed
Wydane: (2006-01-01)

Statins in Non-alcoholic Steatohepatitis
od: Jose D. Torres-Peña, i wsp.
Wydane: (2021-11-01)

Fructose and Non-Alcoholic Steatohepatitis
od: Elke Roeb, i wsp.
Wydane: (2021-02-01)

Obesity, self-reported symptom severity, and quality of life in people with atrial fibrillation: A community-based cross-sectional survey
od: Koutoukidis, D, i wsp.
Wydane: (2020)

Non-alcoholic steatohepatitis in pregnancy: a case report
od: Jonathan Cordivani, i wsp.
Wydane: (2023-09-01)

What proportion of people have a follow-up biopsy in randomized trials of treatments for non-alcoholic steatohepatitis?: A systematic review and meta-analysis.
od: Dimitrios A Koutoukidis, i wsp.
Wydane: (2021-01-01)

The burden of non-alcoholic steatohepatitis: A systematic review of health-related quality of life and patient-reported outcomes
od: Zobair Younossi, i wsp.
Wydane: (2022-09-01)

Role of alcohol metabolism in non-alcoholic steatohepatitis.
od: Susan S Baker, i wsp.
Wydane: (2010-03-01)

Methionine- and choline-deficient diet induces hepatic changes characteristic of non-alcoholic steatohepatitis
od: Éder Marcolin, i wsp.
Wydane: (2011-03-01)

Oyster extracts attenuate pathological changes in non-alcoholic steatohepatitis (NASH) mouse model
od: Mitsugu Watanabe, i wsp.
Wydane: (2016-01-01)

Guidelines for liver transplantation for patients with non-alcoholic steatohepatitis.
od: Newsome, P, i wsp.
Wydane: (2012)

Liraglutide for patients with non-alcoholic steatohepatitis.
od: Dale, A, i wsp.
Wydane: (2016)

Therapeutic approaches for non-alcoholic steatohepatitis
od: Luc F. Van Gaal, i wsp.
Wydane: (2021-09-01)

Validation of NIAAAm-CRP criteria to predict alcohol-associated steatohepatitis on liver histology
od: Rudolf E. Stauber, i wsp.
Wydane: (2024-05-01)

Combined alcoholic and non-alcoholic steatohepatitisKey points
od: Line Carolle Ntandja Wandji, i wsp.
Wydane: (2020-06-01)

Transcriptomic changes in liver transplant recipients with non-alcoholic steatohepatitis indicate dysregulation of wound healing
od: Diogo Pellegrina, i wsp.
Wydane: (2023-05-01)

Developing a New qFIBS Model Assessing Histological Features in Pediatric Patients With Non-alcoholic Steatohepatitis
od: Feng Liu, i wsp.
Wydane: (2022-06-01)

Effect of telmisartan on histological activity and fibrosis of non-alcoholic steatohepatitis: A 1-year randomized control trial
od: Shahinul Alam, i wsp.
Wydane: (2016-01-01)

Glucagon-like peptide 1 decreases lipotoxicity in non-alcoholic steatohepatitis.
od: Armstrong, M, i wsp.
Wydane: (2015)

Association of weight loss interventions with changes in biomarkers of non-alcoholic fatty liver disease: A systematic review and meta-analysis
od: Koutoukidis, DA, i wsp.
Wydane: (2019)

NON-ALCOHOLIC STEATOHEPATITIS IN CHILDREN − A PRACTICAL APPROACH WITH CASE REPORT
od: Ana Šinkovec, i wsp.
Wydane: (2021-10-01)

Application of ursodeoxycholic acid at non-alcoholic and alcohol-induced steatohepatitis
od: Ye. A. Fedos’ina, i wsp.
Wydane: (2010-06-01)

Structure of anaemic conditions comorbid to alcoholic and non-alcoholic steatohepatitis
od: Oksana Khukhlina, i wsp.
Wydane: (2021-05-01)

Non-Alcoholic Steatohepatitis: Clinical and Translational Research
od: Manuela G Neuman, i wsp.
Wydane: (2016-01-01)

Progress on cholesterol metabolism and non-alcoholic steatohepatitis
od: LI Xiao-xiao, SHU Xiang-bing, ZHANG Li
Wydane: (2022-07-01)

Presence and Implications of Sarcopenia in Non-alcoholic Steatohepatitis
od: Gregory Habig, i wsp.
Wydane: (2021-04-01)

Incidental finding of non-alcoholic steatohepatitis-cirrhosis
od: Therese Adrian, i wsp.
Wydane: (2022-01-01)